Zevra Therapeutics ZVRA
NASDAQ ZVRA
$11.03 -0.31 (-2.73%)
As of: Sep 30, 2026 · 2:56 PM EDT

Zevra Therapeutics (ZVRA) Operating Margin (2019 - 2026)

Updated

Zevra Therapeutics' Operating Margin was 42.26% in Q2 2026, up 316.54 percentage points from -274.28% a year earlier but down 101.71 percentage points from the prior quarter.

Analysis

Zevra Therapeutics (ZVRA) Operating Margin (2019 - 2026) Analysis & Trends

On a trailing twelve-month basis, Zevra Therapeutics' Operating Margin was 60.50% through Jun 30, 2026, up 252.59 percentage points year-over-year; for FY2025, it was -59.10%, up 309.37 percentage points from FY2024.

  • Operating Margin shows a five-year change of -16.89 percentage points (FY2020 to FY2025).
  • In earlier years, Operating Margin was -368.47% in FY2024 (-187.84 pp), -180.63% in FY2023 (+238.27 pp), -418.91% in FY2022 (-445.88 pp) and 26.98% in FY2021 (+69.19 pp).
  • Quarterly Operating Margin has moved between -1905.15% (Q2 2022) and 143.97% (Q1 2026) over five years.
  • Compared with a year earlier, Operating Margin has increased for six straight quarters, with an average year-over-year change of +251.30 percentage points over the last eight quarters.
  • The best year-over-year quarter for Operating Margin over five years was Q2 2023 (a gain of 1831.34 percentage points); the worst was Q2 2022 (a drop of 1953.82 percentage points).
  • Per Business Quant data, ZVRA's Operating Margin in the three quarters before Q2 2026 was 143.97% (Q1 2026), 27.27% (Q4 2025) and 15.87% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 28.21%
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 37.86%
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn -3.52%
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 32.97%
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 20.57%
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 34.95%
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn -133.21%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 28.37%
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 37.40%
10 Zevra Therapeutics 672.94 Mn -139.77 Mn 38.18 Mn 42.26%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 42.26%
Mar 31, 2026 143.97%
Dec 31, 2025 27.27%
Sep 30, 2025 15.87%
Jun 30, 2025 -274.28%
Mar 31, 2025 -26.28%
Dec 31, 2024 -128.34%
Sep 30, 2024 -738.00%
Jun 30, 2024 -534.84%
Mar 31, 2024 -598.13%
Dec 31, 2023 -117.31%
Sep 30, 2023 -530.71%
Jun 30, 2023 -73.81%
Mar 31, 2023 -404.00%
Dec 31, 2022 -460.58%
Sep 30, 2022 -230.55%
Jun 30, 2022 -1,905.15%
Mar 31, 2022 -46.89%
Dec 31, 2021 -110.07%
Sep 30, 2021 -113.08%
API Access

Zevra Therapeutics Operating Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-margin&ticker=ZVRA&period=max&api_key=YOUR_API_KEY